Peptide questions · MariTide

How long does MariTide take to work?

Reviewed Evidence: ModeratePublished by PepVault

MariTide’s onset is days–2 weeks, its peak effect comes at 52 weeks (phase 2 endpoint, no plateau yet), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

The timeline’s basis: Phase 1 (Véniant 2024, Nat Metab), phase 2 RCT (Jastreboff 2025, NEJM; NCT05669599), Amgen releases Nov-26-2024, Jun-23-2025 and Feb-3-2026, MARITIME records on ClinicalTrials.gov. Investigational.

MariTide week by week

The library places six of its research notes on MariTide on the days they cover, from day 1 to day 364 and on: 4 on clinical data and 2 on randomized trials.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The MariTide notes by day
WhenThe noteEvidence
Days 1–56 (weeks 1–8)A low start, on purposeClinical data
Days 1–56 (weeks 1–8)Second stepClinical data
Days 29–112 (weeks 5–16)The last step before the target doseClinical data
Days 57–364 (weeks 9–52)The top monthly dose testedRandomized trial
Days 85–364 (weeks 13–52)With type 2 diabetes tooRandomized trial
From day 365 onYear two: keeping it off on lessClinical data
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track MariTide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The MariTide timeline’s milestones

The library’s timeline for MariTide marks 4 points from week 1 to week 104, backed by moderate evidence overall.

  • Week 1: Commonly reported: nausea in the days after the first dose, more likely at a higher start
  • Week 8: Phase 3 finishes its step-up (21, 35, then 70 mg) by about week 8
  • Week 52: Phase 2 endpoint: up to about 20% average loss without diabetes, and not yet levelling off
  • Week 104: Phase 2 second year: Amgen reported most kept their loss on lower monthly or quarterly doses

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why MariTide takes that long

MariTide’s half-life is about 15 days (360 hours), so one dose is about 96.9% cleared after 75 days.

The library’s frequency for MariTide (“Every 4 weeks (monthly)”) isn’t one fixed interval, so this page computes no build-up for it.

The notes on MariTide follow the trials’ dose steps, 21mg, 35mg, 70mg and 420mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

MariTide against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 25 metabolic & GLP-1 compounds, MariTide among them; 17 of the others share its onset of days–2 weeks.

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
MariTideDays–2 weeks52 weeks (phase 2 endpoint, no plateau yet)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
BofanglutideDays–2 weeks52 weeks (phase 3 endpoint)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people
L-Carnitine (injectable)Hours (blood levels rise)12–24 weeks (muscle carnitine, in the one long trial)
Tesofensine1–2 weeks (appetite falls)12–24 weeks (weight loss in the trial)

Questions people ask

How long does MariTide take to work?

MariTide’s onset is days–2 weeks, its peak effect comes at 52 weeks (phase 2 endpoint, no plateau yet), and its typical duration is ongoing, by the library’s timeline (backed by moderate evidence).

When does MariTide reach its peak effect?

By the library’s timeline, MariTide’s peak effect comes at 52 weeks (phase 2 endpoint, no plateau yet), backed by moderate evidence.

How long is MariTide usually run?

The library’s timeline gives MariTide’s typical duration as ongoing; its cycle note says: Used continuously, every 4 weeks, in its trials: 52 weeks in phase 2 and 72 weeks in the phase 3 weight trials.

What does the library say about the first days on MariTide?

Its first note on MariTide, for days 1–56 (weeks 1–8), is “A low start, on purpose”, resting on clinical data.

More on MariTide

Track it in the app

PepVault for iPhone

Track MariTide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo